Toxicity of 6-mercaptopurine/azathioprine in patients with inflammatory bowel disease

被引：16
|
作者：
Marion, JF [1 ]
机构：
[1] Mt Sinai Med Ctr, Mt Sinai Sch Med, New York, NY 10029 USA
来源：
INFLAMMATORY BOWEL DISEASES | 1998年 / 4卷 / 02期
关键词：
adverse reactions; azathioprine; Crohn's disease; drug use in pregnancy; 6-mercaptopurine; pediatric; ulcerative colitis;
D O I：
10.1097/00054725-199805000-00016
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：116 / 117
页数：2
相关论文
共 50 条
  • [41] Azathioprine and 6-mercaptopurine use for inflammatory bowel disease is associated with an increased risk of lymphoma
    Kandiel, AE
    Fraser, AJ
    Korelitz, BI
    Brensinger, CM
    Lewis, JD
    [J]. GASTROENTEROLOGY, 2004, 126 (04) : A19 - A19
  • [42] AZATHIOPRINE/6-MERCAPTOPURINE IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE (IBD) - A SINGLE CENTRE EXPERIENCE
    Costantino, G.
    Sergi, M. D.
    Lo Presti, M. A.
    Della Torre, A.
    Corrente, E.
    Ocera, L.
    Di Benedetto, A.
    Romano, C.
    Fries, W.
    [J]. DIGESTIVE AND LIVER DISEASE, 2008, 40 : S134 - S135
  • [43] Pharmacokinetic analysis of 6-mercaptopurine in patients with inflammatory bowel disease
    Curvers, W
    Gilissen, L
    Derijks, L
    Engels, L
    Bos, L
    Bus, P
    Lohman, J
    Hooymans, P
    Van Deventer, S
    Hommes, D
    [J]. GASTROENTEROLOGY, 2003, 124 (04) : A523 - A523
  • [44] 6-Mercaptopurine and inflammatory bowel disease - Response
    delVal, JH
    Marco, JRM
    Mateu, PN
    Garcia, MYH
    [J]. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 1996, 88 (06) : 456 - 457
  • [45] 6-mercaptopurine metabolite levels in patients with inflammatory bowel disease
    Foster, EN
    Scott, BA
    Dhawan, D
    Sheikh, RA
    Prindiville, T
    [J]. GASTROENTEROLOGY, 2002, 122 (04) : A220 - A221
  • [46] Increased dosing requirements for 6-mercaptopurine and azathioprine in inflammatory bowel disease patients six years and younger
    Grossman, Andrew B.
    Noble, Angela J.
    Mamula, Petar
    Baldassano, Robert N.
    [J]. INFLAMMATORY BOWEL DISEASES, 2008, 14 (06) : 750 - 755
  • [47] Azathioprine/6-mercaptopurine versus 5-aminosalicylic for treatment of inflammatory bowel disease
    Chen, Xin-Lin
    She, Shi-Feng
    Li, Yu-Huang
    Zhang, Wei-Jian
    Tang, Ying-Ting
    Zhuang, Kun-Hai
    Pan, Yun-Bao
    Liu, Feng-Bin
    He, Wei-Ling
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (02): : 1927 - 1936
  • [48] Mean Corpuscular Volume (MCV) to monitor azathioprine and 6-mercaptopurine in Inflammatory Bowel Disease (IBD) patients
    Sarraj, R.
    Pittet, V.
    Michetti, P.
    Felley, C.
    Mottet, C.
    Buclin, T.
    [J]. SWISS MEDICAL WEEKLY, 2011, 141 : 14S - 14S
  • [49] Risk of malignancy in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine: The cape town experience
    Setshedi, M.
    Epstein, D.
    Hift, R.
    Winter, T. A.
    Watermeyer, G. A.
    [J]. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2007, 97 (08): : 606 - 606
  • [50] Risk of Lymphoma in Patients With Inflammatory Bowel Disease Treated With Azathioprine and 6-Mercaptopurine: A Meta-analysis
    Kotlyar, David S.
    Lewis, James D.
    Beaugerie, Laurent
    Tierney, Ann
    Brensinger, Colleen M.
    Gisbert, Javier P.
    Loftus, Edward V., Jr.
    Peyrin-Biroulet, Laurent
    Blonski, Wojciech C.
    Van Domselaar, Manuel
    Chaparro, Maria
    Sandilya, Sandipani
    Bewtra, Meenakshi
    Beigel, Florian
    Biancone, Livia
    Lichtenstein, Gary R.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (05) : 847 - U541
12345